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ABSTRACT
PURPOSE: To evaluate the effect of zafirlukast on capsular contracture around silicone implants by measuring the pressure within the 
implant, using a rat experimental model. 
METHODS: Forty adult female Wistar rats were used. Each one received two silicone implants, one with smooth-surface and the other 
with textured-surface. They were randomly divided into four groups (n=10). The rats of control group I were sacrificed after the implants. 
The remaining animals were subjected to a daily regimen of intra-peritoneal injection for a period of 90 days and they were distributed 
as follows: control group II received 0.9% physiological saline solution; experimental group I received zafirlukast 1.25 mg/kg; and 
experimental group II received zafirlukast 5 mg/kg. The measurement of intra-implant pressure of control group I was determined on the 
surgery day and in other groups on the ninetieth day, after being sacrificed. RESULTS: In the evaluation of textured implants there was 
an increase of internal pressure in the control group II, and there was no increase in the experimental groups. Compared to the controls 
there were not significant differences in smooth implants. 
CONCLUSION: Zafirlukast reduced the risk of developing capsular contracture around silicone implants with textured surface. 
Key words: Breast Implants. Implant Capsular Contracture. Leukotriene Antagonists. Rats.
RESUMO
OBJETIVO: Avaliar o efeito do zafirlukast na contratura capsular ao redor de implantes de silicone, através da aferição da pressão 
intra-implante, utilizando-se um modelo experimental de ratos.
MÉTODOS: Quarenta ratos fêmeas Wistar foram utilizados. Cada um recebeu dois implantes de silicone, sendo um com superfície 
lisa e outro texturizada. Foram divididos aleatoriamente em quatro grupos (n=10). Os ratos do grupo controle I foram sacrificados após 
o implante. O restante dos animais foi submetido a um regime diário de injeção intraperitoneal por um período de 90 dias e foram 
distribuídos: grupo controle II recebeu solução salina fisiológica 0,9%, grupo experimental I recebeu zafirlukast 1,25 mg/kg, e grupo 
experimental II recebeu zafirlukast 5 mg/kg.  O grupo controle II recebeu solução salina; grupo experimental I, 1,25 mg/kg/dia de 
zafirlukast; grupo experimental II, 5mg/kg/dia de zafirlukast. A aferição da pressão intra-implante do grupo controle I foi averiguada no 
dia do ato operatório, e nos outros grupos no nonagésimo dia, após serem sacrificados. 
RESULTADOS: Na avaliação dos implantes texturizados houve aumento da pressão interna no grupo controle II e, não se observou 
aumento nos grupos experimentais. Na comparação com os controles não foram observadas diferenças significativas nos implantes lisos. 
CONCLUSÃO: O Zafirlukast reduziu o risco de desenvolver contratura capsular em torno de implantes de silicone com superfície 
texturizada.
Descritores: Implantes de Mama. Contratura Capsular em Implantes. Antagonistas de Leucotrienos. Ratos.
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Introduction
The search for breast implant surgery is increasing 
each year. According to the American Society for Aesthetic 
Plastic Surgery (ASAPS)1, in 2009, over 289.000 procedures 
were conducted exclusively for breast augmentation. In Brazil, 
according to the Brazilian Society of Plastic Surgery (SBCP)2, this 
number is over 150.000. 
In this type of surgery, the capsular contracture is the 
main complication3,4 observed in up to 50%4,5 of patients in two 
years following the surgery3-7. The fibrous tissue formed around 
the prosthesis promotes its compression and can cause esthetic 
involvement (distortion, asymmetry and hardening of the breast) 
and painful symptoms4-9, making it sometimes frustrating for both 
patients and surgeons5,6.
The standard treatment is capsulectomy with implant 
replacement, which would require additional surgery, with all 
its risks and inherent burdens3,6-10. The search for prevention and 
less morbid/invasive treatment for this phenomenon has been the 
subject of several studies; however, so far, no study has clearly 
demonstrated their effectiveness3-11. 
Although the actual cause of capsular contracture is still 
unknown, most authors rely on the hypothesis of a multifactorial 
process3-5,7-9 that has inflammation as a common denominator3,7,8. 
Currently, pharmacological inhibition of this inflammation around 
implants is the main focus of investigation7,8, in the search for 
prevention and successful treatment of this problem3,7,8.
It deserves mention a pioneering study conducted by 
Schlesinger et al.12, which showed a significant improvement 
in the degree of capsular contracture with the use of zafirlukast 
(Accolate®, AstraZeneca), a leukotriene antagonist, for a period 
of 1 to 3 months, to the extent that, in cases of some women for 
whom surgical procedures had already been indicated, this proved 
unnecessary. As a consequence, some authors have attempted 
to clarify the issue of the mechanisms involved with this drug 
in the prevention and treatment of capsular contracture5,8,10-18. 
Accordingly, new investigations are important to confirm the 
beneficial effect of this drug. 
The purpose of this experimental study is to evaluate 
the effect of zafirlukast on capsular contracture around silicone 
implants by measuring the pressure within the implant, using a rat 
experimental model.
Methods 
The experimental protocol was approved by the 
Research Ethics Committee of the Federal University of Sao Paulo 
(UNIFESP). The rats were kept according to the guidelines of the 
Guide for the Care and Use of Laboratory Animals (Institute for 
Laboratory Animal Research, 1996) and according to the ethical 
principles of the Brazilian College on Animal Experimentation 
(COBEA).
Forty adult female Wistar EPM-1 rats weighing 
200 to 250g were used. The animals were kept in light-dark 
cycles (12/12h) with free access to food and water. All surgical 
procedures were performed under general anesthesia by intra-
peritoneal administration of 25 mg/kg of tiletamine hydrochloride/
zolazepam hydrochloride (Zoletil®, VIRBAC, Sao Paulo, Brazil).
Experimental groups and surgical procedure
On surgeries, a total of 80 mini silicone implants filled 
with silicone gel, round-based, 2.2 cm in diameter, volume of 
two ml and with the same internal pressure were used. Forty 
mini-implants had textured-surfaces and 40 smooth-surfaces. All 
were produced and donated by the company SILIMED® (Rio de 
Janeiro, Brazil).
Surgical procedures were carried out according to the 
experimental model of capsular contracture in silicone implants 
previously reported by our group19. Rats underwent a two-cm 
incision perpendicular and symmetrical to the midline, between 
the middle and distal thirds of the animals back (between the 
posterior-superior iliac spines), involving skin and panniculus 
carnosus. 
Following, two tunnels were built beneath the panniculus 
carnosus, until and between the shoulder blades, on each side of 
the animal, taking care not to communicate them. The implants 
were inserted through the incision and placed on the scapulas; 
the smooth surface implants were positioned on the right and the 
textured ones on the left (Figure 1). 
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FIGURE 1 - Rat after placement of implants on the scapulas (arrows).
Following this phase, four groups of 10 rats were formed 
at random. The control group I (CI) received only the implantation 
of prostheses. The remaining animals were subjected to a daily 
regimen of intra-peritoneal injections for a period of 90 days and 
they were distributed as follows: control group II (CII) received 
0.9% physiological saline solution; experimental group I (EI) 
received zafirlukast 1.25 mg/kg; and experimental group II (EII) 
received zafirlukast 5 mg/kg. The animals of CI group were 
sacrificed on the day of surgery and the remaining ones after 90 
days, by a lethal anesthetic dose.
Measuring the internal pressure of mini-implants
To measure the internal pressure of each implant was 
performed the pressure measurement generated by the influx of 
distilled water into the implant; after the opening of the paths that 
connected the implant to the gauge it was made the reading of 
this reflux pressure, which inferred the compliance of the capsule 
(Figure 2). For this, it was used a pressure transducer, which 
transformed the mechanical information of pressure into electrical 
signals and a signal amplifier (TIVA®, VECTUS, Sao Paulo, 
Brazil), which read the electrical signals and transformed them 
into Pascal measurements (0 to 1500 Pascal).
FIGURE 2 - Illustration showing the layout of pressure measurement 
inside the mini-implants after distilled water infusion. Water is injected 
into the implant and then ways of the pressure gauge and implant are 
maintained patent for water reflux, which occurs according to the 
complacency of the capsule. The mechanical energy is transformed into 
an electrical signal that is read by the device.
 
The pressure transducer was connected to the gauge-
reader. A silicone hose was connected to another output. This hose 
was connected to a three-way system. In one of the ways it was 
connected a syringe of 1 ml; and in the other one, a nº 19 scalp. 
The whole system was filled with distilled water; the transducer 
and the silicone hose were filled previously and connected to 
the system, taking care not to let any air bubbles. This system 
remained untouched (without disconnecting) until the end of the 
measurements. 
The scalp, which was changed at every measurement, 
was connected to the system and filled with distilled water through 
the syringe connected to the other way. After the system was fully 
filled, the ways from the scalp to the gauge were opened, and the 
initial value of zero was verified (based on atmospheric pressure). 
The syringe was then filled with 0.5 ml of distilled water and 
reconnected to the system.
After removal of hair over the implant area, they were 
positioned at the same level of the system and the “scalp” was 
introduced into the animal (always the same length of the needle 
was inserted into the animal). Great care was taken that all 
connections were at the same level of “zero” calibrated, including 
the needle inserted into the rat, which had 90 degrees with the 
syringe in all axes. 
Since the gel is very viscous, it did not flow into the 
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system; therefore, a controlled amount of this fluid (0.3 ml) was 
injected into the implant through the syringe. After this procedure, 
the ways of the reader and of the scalp were open, so that 
according to the internal pressure of the mini-implants there was 
a variable reflux of water into the transducer, which transformed 
this mechanical signal into electrical signals read by the reader as 
a Pascal pressure measurement.
Statistical analysis
In the descriptive analysis, data were summarized as 
means, medians, standard deviations, standard errors, 1st and 
3rd quartiles, minimum and maximum values. For comparisons 
between groups and between types of implants generalized linear 
models were used with repeated measures considering two factors: 
group (CI, CII, EI and EII) and type of implant (smooth and 
textured). The used statistical programs were: Statistical Package 
for Social Sciences (SPSS) version 11.0 and SAS version 8.01 
for Windows. Values were considered significant for a confidence 
interval of 95% (p<0.05). 
Results
The final sample analyzed consisted of 33 rats, carrying 
33 smooth implants and 31 textured ones. One animal in CI group 
showed extrusion of two implants and two animals presented 
implants attached to each other; therefore, they were excluded 
(remaining 7 rats, 7 smooth, and 7 textured). In group EI one rat 
was sacrificed due to eye loss caused by local infection; a rat with 
implants adhered to one another and a loss by measurement error 
(remaining 7 rats, 7 smooth, and 7 textured). In EII group one 
rat died of peritonitis because of a probable accident puncture; 
and two rats with loss of textured implants after necrosis of the 
overlying skin (remaining 9 rats, 9 smooth, and 7 textured).
Internal pressure of mini-implants 
The value distribution of internal pressures of mini-
implants, after the infusion of 0.3 ml of distilled water, in the four 
groups, is shown in form of box-plot in Figure 3.
FIGURE 3 - Boxplot showing the dispersion of the values of intra-
implant pressure after infusion of 0.3 ml of distilled water in the four 
groups. The symbols “O” e “*” indicate the outliers.
Analyzing the variations of internal pressure of the 
textured implants, it was found a significant difference (p=0.0047) 
between CI and CII, with the later showing the highest post-
infusion pressure, which can be characterized as capsular 
contracture. In the comparison of CI group with experimental 
groups (EI and EII) no difference was found, which indicates 
that these groups (EI and EII) showed no capsular contracture. In 
groups with smooth implants capsular contracture was not found 
either in the group that received only saline solution or in groups 
that received zafirlukast (Table 1).
The comparative analysis between implant types 
(textured and smooth) for all groups showed no differences (Table 
2). 
TABLE 1 – Comparative analysis group by group among 
pressures encountered, according to the type of implant surface. 
CI = control group I; CII = control group II; EI = experimental group I; 
EII = experimental group II. *Statistically significant.
Comparison
p-value
Smooth Textured
CI X CII 0.1925 0.0047*
CI X EI 0.8383 0.2337
CI X EII 0.4781 0.1657
CII X EI 0.3068 0.0995
CII X EII 0.5211 0.1413
EI X EII 0.6533 0.8509
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TABLE 2 – Comparative analysis of the pressures found 
according to the type of implant surface in the four groups.
CI = control group I; CII = control group II; EI = experimental group I; 
EII = experimental group II.
Discussion
Since the first reports on capsular contracture in the 
literature, many studies have been conducted in an attempt to 
prevent its development, using different drugs (such as antibiotics, 
anti-neoplastic agents and steroids) administered locally or 
systemically, but with disappointing results3-6,8,10,11.
It deserves attention the possibility of an oral drug 
for the treatment of a complication that has serious physical, 
psychological and financial consequences and for which the 
only effective treatment is surgery14. Zafirlukast is commonly 
used in the treatment of asthma. It is a competitive antagonist 
of leukotriene receptor D4 and E4 and the occupation of these 
receptors by cysteinyl leukotrienes has been implicated in the 
pathophysiology of asthma, acting in stages such as contraction of 
bronchial smooth muscles, determining, among other actions, the 
reduction of airway edema, alteration of cellular activity related 
to inflammation, preventing the increase of vascular permeability 
and inhibition of eosinophil influx20.
Recent research has shown that its use in animals10,13,14 
and clinical trials8,12,15-17 determines a reduction in capsular 
formation around the silicone implants10,13,14. The use of 
zafirlukast also reduces pain, distortion of breast8,15,16 and can 
reverse up to two degrees (according to Baker’s classification) 
in the contracture of capsules already established8. Biomolecular 
studies5,11 demonstrated that leukotriene receptors (CysLT) are 
involved in the formation of fibrous capsules around the breast 
implants. All these data add to speculation about the importance of 
leukotriene antagonists in the prevention and treatment of capsular 
contracture.
In this study, the option for silicone prostheses and not 
saline ones was due to the greater incidence of capsular contracture 
found in the use of the former9; the observation time (three 
months) was based on other studies with rats, which showed that 
most of the capsular contractures occurred during this period21. 
As for the method of measuring the complacency of the capsule, 
it was chosen the method of infusion liquid which had been 
described by other authors21-23. The use of pressure measurement 
system was necessary because it seems to be the most objective 
method to assess capsular contracture. Baker’s classification and 
applanation tonometry did not seem very appropriate to investigate 
contractures in rats.
The use of implants with textured and smooth surfaces 
was due to the fact that they behave differently regarding the 
occurrence of capsular contracture6,7; however, this matter is not 
yet consensus in the scientific literature7. Therefore, it was opted 
for the allocation of two types of prostheses in the same rat, so that 
different responses to the use of zafirlukast could be verified.
The effect of zafirlukast in reducing capsular contracture 
on textured implants observed in this experiment is consistent 
with findings from previous studies10,13,14, which showed that 
the application of leukotriene antagonist reduced the number of 
vessels, capsular thickness, collagen density, number of mast cells, 
eosinophils and myofibroblasts around the prosthesis compared 
with control. However, the issue of smooth prostheses lacks 
further responses. 
Besides the zafirlukast reducing the formation of capsule 
around implants (demonstrated in previous studies10,13,14, the 
decrease of the contraction had not been demonstrated and by 
measuring the internal pressures of mini-implants, the present 
study comes to fill this gap.
Conclusion
Zafirlukast reduced the risk of developing capsular 
contracture around silicone implants with textured surface in this 
rat model.
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